Skip to content
NexaReport logo with abstract N icon and globe representing global news platform

  • Business News
  • Entrepreneurship
  • Investments
  • Startups
  • Stock Market
  • Uncategorized
NexaReport logo with abstract N icon and globe representing global news platform

  • Business News
  • Entrepreneurship
  • Investments
  • Startups
  • Stock Market
  • Uncategorized

Jim Cramer

  • Investments

Jim Cramer Netflix Advice

similispharma@gmail.comAugust 16, 20260

InvestmentsBy Priya SharmaAugust 16, 20268 min read Key Takeaways Investors reconsider Netflix holdings amid slowing growth Cramer advises averaging down…

  • Startups

Jim Cramer Slams DoorDash Short

similispharma@gmail.comAugust 15, 20260

StartupsBy Priya SharmaAugust 15, 20267 min read Key Takeaways Investors shorted DoorDash due to Uber's market presence Cramer deemed the…

  • Business News

Cramer Backs CME Cboe Dominance

similispharma@gmail.comAugust 8, 20260

Business NewsBy Kavita NairAugust 8, 20268 min read Key Takeaways Earnings surge 15% at CME Group Cboe joins CME in…

  • Stock Market

Jim Cramer Fleeing AI Stocks

similispharma@gmail.comAugust 3, 20260

Stock MarketBy Rohan DesaiAugust 3, 20267 min read Key Takeaways Investors flee AI stocks Wall Street shifts to Salesforce Markets…

  • Entrepreneurship

Jim Cramer Backs Element Solutions

similispharma@gmail.comJuly 12, 20260

EntrepreneurshipBy Priya SharmaJuly 12, 20268 min read Key Takeaways Investors target Element Solutions Inc for growth potential Markets analyze ESI's…

  • Business News

Jim Cramer Backs Nebius Stock

similispharma@gmail.comJuly 9, 20260

Business NewsBy Rohan DesaiJuly 9, 20266 min read Key Takeaways Investors flock to Nebius Nebius dominates Canada's clean energy Innovations…

  • Startups

Jim Cramer’s Weakest Stock BAC

similispharma@gmail.comJuly 8, 20260

StartupsBy Kavita NairJuly 8, 20267 min read Key Takeaways Investors reassess BAC's prospects Markets weigh Cramer's verdict BAC's returns disappoint…

  • Stock Market

Jim Cramer’s Top Stock Pick

similispharma@gmail.comJuly 4, 20260

Stock MarketBy Arjun MehtaJuly 4, 20268 min read Key Takeaways Investors scramble to buy C3.ai after Cramer's endorsement Cramer selects…

  • Investments

Jim Cramer on Palantir Growth

similispharma@gmail.comJune 23, 20260

InvestmentsBy Rohan DesaiJune 23, 20268 min read Key Takeaways Investors flock to Palantir Growth accelerates despite stock slowdown Cramer praises…

  • Startups

Jim Cramer Backs Bank Mergers

similispharma@gmail.comJune 23, 20260

StartupsBy Rohan DesaiJune 23, 202611 min read Key Takeaways Mergers accelerate banking consolidation Banco Santander excels globally Cramer endorses strategic…

  • 1
  • 2
  • 3
  • …
  • 5

RECENT POSTS

  • Ondo Stocks Volume Hits $27B, Tokenized Equity Platform Holds Above $1B — Analysis and Market Outlook
  • NOW Stock Has Rebounded Over 54% — Why ServiceNow’s Rally Could Have Further Room To Run — Analysis and Market Outlook
  • Alphabet Stock To $515: 3 Reasons The Bull Case Is Getting Stronger — Analysis and Market Outlook
  • Workday Has Its Best Day In A Decade On Report Of A Potential $43 Billion Buyout — Analysis and Market Outlook
  • Bending Spoons Beats On Earnings In Its Public Market Debut Quarter. Investors Focus On The Fine Print Instead — Analysis and Market Outlook

CATEGORIES

  • Business News (2,042)
  • Entrepreneurship (2,102)
  • Investments (2,113)
  • Startups (2,109)
  • Stock Market (2,054)

Archives

  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026

Categories

  • Business News
  • Entrepreneurship
  • Investments
  • Startups
  • Stock Market
  • About Us
  • Contact
  • Contact Us
  • Disclaimer
  • Help Center
  • Home
  • Privacy Policy
  • Terms & Conditions
Online Newspaper - News / Magazine WordPress Theme 2026.
Back To Top